Campuses

As France's leading biocluster, Genopole is an incubator for cutting-edge projects in biotechnology. Located in the city of Évry, just south of Paris, Genopole provides a unique environment for scientists and entrepreneurs seeking to advance research and innovation.

Discover >

Advantages

Genopole accompanies researchers, postdocs and start-up entrepreneurs through all the phases of their projects to ensure the best possible conditions for business development.

Discover >

Genopole’s citizens

Every day, at Genopole, researchers, entrepreneurs and students cross paths, share ideas and unite forces in a veritable melting pot for innovation.

Discover >

Highlights

Giving wings to research and empowering employment in our community are cornerstones of Genopole's mission. Catch up on recent scientific advances, the accomplishments of our biotech actors and the events that enliven the biocluster.

Discover >

Innovate with us

Discover >
Company

Abolis Biotechnologies


5, rue Henri Desbruères – Building 6
91030 EVRY – France
Phone: +33 (0)6 95 41 01 87
Email: contact@abolis.fr

CEO: Cyrille PAUTHENIER
Web Site >
ABOLIS - entreprise génopolitaine ABOLIS - entreprise génopolitaine

Lauréat du Concours Genopole

#Industrial Biotech

  • Synthetic biology
  • Metabolic engineering
  • Bioproduction
  • Bio-based molecules
  • Bioeconomy
  • Sustainable development

 

Field of Activity


Development of custom-order microorganisms able to produce molecules of interest in health, nutrition, cosmetics, chemistry and agriculture.

BACKGROUND

Abolis merges bioinformatic, genetic and robotic processes to redesign metabolic pathways. With its technology, the company creates industrial microbial strains capable of producing molecules of interest via fermentation.

The underlying concept is to harness and improve upon natural biosynthesis processes.

DESCRIPTION OF THE PRODUCTS / SERVICES /TECHNOLOGY

With its synthetic biology platform, Abolis reliably provides businesses with the existing or novel molecules they need while maintaining sustainability (bio-based and biodegradable materials) and significantly reducing the environmental impact of molecular production. Abolis contributes to all project phases: from initial study, to intellectual property protection and on through to industrialization.

ACCOMPLISHMENTS / COLLABORATIONS / HIGHLIGHTS

In 2014 Abolis Biotechnologies was a start-up phase laureate of the Innovation 2030 Worldwide Innovation Challenge. Abolis has partnerships with such groups as Lesaffre and Givaudan and has filed six patents.

Collaborations sought

Abolis pursues its own research program.

In parallel, the company establishes industrial partnerships to:

  • produce its chemical compounds in a bio-based manner,
  • secure supply of raw materials,
  • reduce production costs.
  • Futher Informations

    Strengths:

    Europe counts few actors in metabolic engineering; the technology provided by Abolis gives its clients a head start for their CSR strategies.

Share
Companies Directory

#Industrial Biotech


In same field

FABMID - entreprise génopolitaine

FABMID

Fabmid develop a cutting-edge DNA vector to reduce the cost and improve efficiency of cell and gene therapy

Discover
Proteinea - Genopole's company

Proteinea

Production as a service (PaaS) platform capable of producing recombinant proteins & enzymes cheaper and on a scale.

Discover
Altar - entreprise génopolitaine

Altar

Altar is a specialist in the conception and operation of automated fluidic continuous culture systems for adaptive laboratory evolution and the development of microbial strains for industry.

Discover
Yposkesi - Genopole's Company

Yposkesi

YposKesi is the first French company to develop and manufacture gene and cell therapy products for rare diseases.

Discover
Watchfrog Laboratory - Genopole's company

WatchFrog

WatchFrog markets in vivo biotechnological solutions for environmental risk assessment and the evaluation of the therapeutic, toxic or pollutant potential of all types of chemical, cosmetic or pharmaceutical compounds.

Discover
Pymabs - Genopole's Company

Pymabs

R & D services in the field of transient expression of recombinant proteins in plants.

Discover
Pharming - Genopole's company - Logo 2021

PHARMING

Pharming specializes in the production of recombinant proteins in transgenic rabbit milk.

Discover
Glowee - Genopole's company

Glowee

Glowee is a cleantech startup developing a disruptive lighting technology based on bioluminescence (the natural light-producing property of certain living organisms).

Discover
Global Bioenergies - Genopole's company

Global Bioenergies

Global Bioenergies is developing a process to convert renewable resources into hydrocarbons through fermentation.

Discover
View all >
With support